Perpetua Medical AB (publ) (STO:PERP.B)
Sweden
· Delayed Price · Currency is SEK 3.630
-0.110 (-2.94%)
Mar 9, 2026, 1:54 PM CET
Perpetua Medical AB Company Description
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden.
The company provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations.
The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden. Perpetua Medical AB (publ) operates as a subsidiary of Nolsterby Invest AB.
Perpetua Medical AB (publ)
| Country | Sweden |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Anders Hedlund |
Contact Details
Address: Knivstagatan 8 Uppsala, Uppsala County SE-753 23 Sweden | |
| Phone | 46 1 87 11 332 |
| Website | perpetuamedical.se |
Stock Details
| Ticker Symbol | PERP.B |
| Exchange | Nasdaq Stockholm |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0022726311 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Hans Dahlin | Founder and Advisor to Chief Executive Officer |
| Anders Hedlund | Refounder and Chief Executive Officer |
| Camilla Lonn | Chief Financial Officer |